FDA Inspection
Eurofins Lancaster Laboratories, IncEurofins Lancaster Laboratories, Inc – FDA Inspection, May 6, 2011
Record Details
This FDA Inspection record concerns Eurofins Lancaster Laboratories, Inc, with an inspection on May 6, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 6, 2011
- Product Type
- Drugs
View Company Profile
ID · 9e056c66-572d-4816-ba9f-ca1de618a628
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 724139
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Eurofins Lancaster Laboratories, Inc
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 30, 2025 | VAI | Detroit District Office | Drug Quality Assurance |
| December 10, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 23, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 4, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eurofins Lancaster Laboratories, Inc
- FDA Inspection 1272016 - 2025-05-30
- FDA Inspection 1160560 - 2021-12-10
- FDA Inspection 1080439 - 2019-01-23
- FDA Inspection 1045298 - 2018-02-23
- FDA Inspection 1001348 - 2016-11-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.